Cargando…

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

IMPORTANCE: Aflibercept biosimilars can expand available treatment options in retinal diseases and have the potential to improve patient access to safe and effective therapy. OBJECTIVE: To establish equivalence in efficacy and similarity in safety, pharmacokinetics, and immunogenicity of SB15 and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Se Joon, Bradvica, Mario, Vajas, Attila, Sagong, Min, Ernest, Jan, Studnicka, Jan, Veith, Miroslav, Wylegala, Edward, Patel, Sunil, Yun, Cheolmin, Orski, Michal, Astakhov, Sergei, Tóth-Molnár, Edit, Csutak, Adrienne, Enyedi, Lajos, Kim, Taehyung, Oh, Inkyung, Jang, Hyerin, Sadda, SriniVas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251242/ https://www.ncbi.nlm.nih.gov/pubmed/37289448 http://dx.doi.org/10.1001/jamaophthalmol.2023.2260

Ejemplares similares

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes
por: Bressler, Neil M, et al.
Publicado: (2023)

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
por: Woo, Se Joon, et al.
Publicado: (2020)

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
por: Nemcansky, Jan, et al.
Publicado: (2019)

Relationship between distribution and severity of non-perfusion and cytokine levels and macular thickness in branch retinal vein occlusion
por: Ryu, Gahyung, et al.
Publicado: (2021)

Aflibercept Treatment Leads to Vascular Abnormalization of the Choroidal Neovascularization
por: Wylęgała, Adam, et al.
Publicado: (2018)

Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
por: Lashay, Alireza, et al.
Publicado: (2020)

Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study
por: Chan, Clement K., et al.
Publicado: (2020)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

Focus on external limiting membrane and ellipsoid zone in diabetic macular edema
por: Saxena, Sandeep, et al.
Publicado: (2021)

Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial
por: Bressler, Neil M., et al.
Publicado: (2022)

Is virtual existence our new reality?
por: Sarraf, David, et al.
Publicado: (2020)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
por: Babiuch, Amy S., et al.
Publicado: (2021)

The Impact of Robotic Fractionated Radiotherapy for Benign Tumors of Parasellar Region on the Eye Structure and Function
por: Orski, Michal, et al.
Publicado: (2023)

Wide-field angiography in retinal vein occlusions
por: Tan, Colin S., et al.
Publicado: (2019)

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation
por: Corvi, Federico, et al.
Publicado: (2020)

Pearls and Pitfalls of Optical Coherence Tomography Angiography Imaging: A Review
por: Borrelli, Enrico, et al.
Publicado: (2019)

Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab
por: Corradetti, Giulia, et al.
Publicado: (2020)

Automatic Segmentation in Multiple OCT Layers For Stargardt Disease Characterization Via Deep Learning
por: Mishra, Zubin, et al.
Publicado: (2021)

PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB
por: Lee, Hyuna, et al.
Publicado: (2023)

Management of Neovascular Age-Related Macular Degeneration during the COVID-19 Pandemic
por: Corradetti, Giulia, et al.
Publicado: (2020)

Optical Coherence Tomography Angiography of the Choriocapillaris in Age-Related Macular Degeneration
por: Scharf, Jackson, et al.
Publicado: (2021)

Current status and future possibilities of retinal imaging in diabetic retinopathy care applicable to low- and medium-income countries
por: Attiku, Yamini, et al.
Publicado: (2021)

A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment
por: Holz, Frank G., et al.
Publicado: (2022)

Impact of image quality on OCT angiography based quantitative measurements
por: Al-Sheikh, Mayss, et al.
Publicado: (2017)

Impact of Scan Tilt on Quantitative Assessments Using Optical Coherence Tomography Angiography
por: Ji, Yong Sok, et al.
Publicado: (2020)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

Vortex Vein Imaging: What Can It Tell Us?
por: Verma, Aditya, et al.
Publicado: (2021)

Ultra-Widefield Indocyanine Green Angiography Reveals Patterns of Choroidal Venous Insufficiency Influencing Pachychoroid Disease
por: Bacci, Tommaso, et al.
Publicado: (2022)

The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
por: Musiał-Kopiejka, Magdalena, et al.
Publicado: (2022)

One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity
por: Kwon, Ji Min, et al.
Publicado: (2021)

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters
por: Sadda, SriniVas R., et al.
Publicado: (2019)

Comparison and Repeatability of High Resolution and High Speed Scans from Spectralis Optical Coherence Tomography Angiography
por: Corvi, Federico, et al.
Publicado: (2020)

Automated Retinal Layer Segmentation Using Graph-based Algorithm Incorporating Deep-learning-derived Information
por: Mishra, Zubin, et al.
Publicado: (2020)

A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis
por: Sarao, Valentina, et al.
Publicado: (2019)

Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial
por: Velaga, Swetha Bindu, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
por: Ryu, Gahyung, et al.
Publicado: (2021)

Impact of mydriasis in fluorescence lifetime imaging ophthalmoscopy
por: Sadda, SriniVas R., et al.
Publicado: (2018)

Repeatability of Fluorescence Lifetime Imaging Ophthalmoscopy in Normal Subjects With Mydriasis
por: Kwon, Soonil, et al.
Publicado: (2019)

Variability of Retinal Thickness Measurements in Tilted or Stretched Optical Coherence Tomography Images
por: Uji, Akihito, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f5jc7lmqtl7vned0e20vabgvri